Showing content from https://pubmed.ncbi.nlm.nih.gov/32355638/ below:
Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system
Editorial
doi: 10.1016/j.toxrep.2020.04.012. eCollection 2020. Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system
Affiliations
Affiliations
- 1 Laboratory of Mol. Biology and Immunology, Department of Pharmacy, University of Patras, Panepistimiopolis, 26500, Greece.
- 2 School of Public Health, Department of Public and Community Health, University of West Attica, 11521, Greece.
- 3 Departments of Social and Behavioral Science and Epidemiology, College of Global Public Health, New York University, USA.
- 4 Department Medicine, University of Crete, Greece.
- 5 Department of Biochemistry and Biotechnology, University of Thessaly, Larisa, 41500, Greece.
- 6 School of Medicine, University of Patras, Panepistimiopolis, 26500, Greece.
Item in Clipboard
Editorial
Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system
Konstantinos Farsalinos et al. Toxicol Rep. 2020.
doi: 10.1016/j.toxrep.2020.04.012. eCollection 2020. Affiliations
- 1 Laboratory of Mol. Biology and Immunology, Department of Pharmacy, University of Patras, Panepistimiopolis, 26500, Greece.
- 2 School of Public Health, Department of Public and Community Health, University of West Attica, 11521, Greece.
- 3 Departments of Social and Behavioral Science and Epidemiology, College of Global Public Health, New York University, USA.
- 4 Department Medicine, University of Crete, Greece.
- 5 Department of Biochemistry and Biotechnology, University of Thessaly, Larisa, 41500, Greece.
- 6 School of Medicine, University of Patras, Panepistimiopolis, 26500, Greece.
Item in Clipboard
No abstract available
PubMed Disclaimer
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Fig. 1
BLAST-P alignment of the SARS-CoV-2…
Fig. 1
BLAST-P alignment of the SARS-CoV-2 protein against Muscarinic toxin like protein (A) and…
Fig. 1
BLAST-P alignment of the SARS-CoV-2 protein against Muscarinic toxin like protein (A) and Cobratoxin (Naja siamensis) (B) indicating regions with relatively high identity.
Fig. 2
Progression of COVID-19 after SARS-CoV-2…
Fig. 2
Progression of COVID-19 after SARS-CoV-2 infection.
Fig. 2
Progression of COVID-19 after SARS-CoV-2 infection.
Similar articles
- Cholinergic dysfunction in COVID-19: frantic search and hoping for the best.
Nadwa EH, Al-Kuraishy HM, Al-Gareeb AI, Elekhnawy E, Albogami SM, Alorabi M, Batiha GE, De Waard M. Nadwa EH, et al. Naunyn Schmiedebergs Arch Pharmacol. 2023 Mar;396(3):453-468. doi: 10.1007/s00210-022-02346-9. Epub 2022 Dec 3. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36460816 Free PMC article. Review.
Cited by
- Tobacco and COVID-19: a crisis within a crisis?
Alla F, Berlin I, Nguyen-Thanh V, Guignard R, Pasquereau A, Quelet S, Schwarzinger M, Arwidson P. Alla F, et al. Can J Public Health. 2020 Dec;111(6):995-999. doi: 10.17269/s41997-020-00427-x. Epub 2020 Oct 14. Can J Public Health. 2020. PMID: 33052586 Free PMC article.
- Toxic metal exposure as a possible risk factor for COVID-19 and other respiratory infectious diseases.
Skalny AV, Lima TRR, Ke T, Zhou JC, Bornhorst J, Alekseenko SI, Aaseth J, Anesti O, Sarigiannis DA, Tsatsakis A, Aschner M, Tinkov AA. Skalny AV, et al. Food Chem Toxicol. 2020 Dec;146:111809. doi: 10.1016/j.fct.2020.111809. Epub 2020 Oct 16. Food Chem Toxicol. 2020. PMID: 33069759 Free PMC article.
References
-
- Goumenou M., Sarigiannis D., Tsatsakis A., Anesti O., Docea A.O., Petrakis D., Tsoukalas D., Kostoff R., Rakitskii V., Spandidos D.A., Aschner M., Calina D. COVID 19 in Northern Italy: an integrative overview of factors possibly influencing the sharp increase of the outbreak (Review) Mol. Med. Rep. 2020;0.0(1899) 0-0. - PMC - PubMed
-
- Goumenou M., Spandidos D.A., Tsatsakis A. "[Editorial] Possibility of transmission through dogs being a contributing factor to the extreme Covid 19 outbreak in North Italy. Mol. Med. Rep. 2020;21.6:2293–2295. - PMC - PubMed
-
- Docea A.O., Tsatsakis A., Albulescu D., Cristea O., Zlatian O., Vinceti M., Moschos S.A., Tsoukalas D., Goumenou M., Drakoulis N., Dumanov J.M., Tutelyan V.A., Onischenko G.G., Aschner M., Spandidos D.A., Calina D. A new threat from an old enemy: Re emergence of coronavirus (Review) Int. J. Mol. Med. 2020;45.6:1631–1643. - PMC - PubMed
-
- Skalny A.V., Rink L., Ajsuvakova O.P., Aschner M., Gritsenko V.A., Alekseenko S., Svistunov A.A., Petrakis D., Spandidos D.A., Aaseth J., Tsatsakis A., Tinkov A.A. Zinc and respiratory tract infections: perspectives for COVID 19 (Review) Int. J. Mol. Med. 2020;0.0(1899) 0-0. - PMC - PubMed
-
- Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., Liu L., Shan H., Lei C.L., Hui D.S.C., Du B., Li L.J., Zeng G., Yuen K.Y., Chen R.C., Tang C.L., Wang T., Chen P.Y., Xiang J., Li S.Y., Wang J.L., Liang Z.J., Peng Y.X., Wei L., Liu Y., Hu Y.H., Peng P., Wang J.L.M., Liu J.Y., Chen Z., Li G., Zheng Z.J., Qiu S.Q., Luo J., Ye C.J., Zhu S.Y. Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2002032. - DOI - PMC - PubMed
RetroSearch is an open source project built by @garambo
| Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3